Statins use and female lung cancer risk in Taiwan

In this present study, we found that the use of rosuvastatin with cumulative using duration >12 months could correlate with 2.8-fold increased risk of lung cancer in women. We did not have specific comments on these results. Further prospective clinical studies of statins use are needed to elucid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Shih-Wei, Liao, Kuan-Fu, Lin, Cheng-Li, Sung, Fung-Chang, Cheng, Ya-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2012
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532353/
https://www.ncbi.nlm.nih.gov/pubmed/23272648
http://dx.doi.org/10.3402/ljm.v7i0.20123
_version_ 1782254295809261568
author Lai, Shih-Wei
Liao, Kuan-Fu
Lin, Cheng-Li
Sung, Fung-Chang
Cheng, Ya-Hsin
author_facet Lai, Shih-Wei
Liao, Kuan-Fu
Lin, Cheng-Li
Sung, Fung-Chang
Cheng, Ya-Hsin
author_sort Lai, Shih-Wei
collection PubMed
description In this present study, we found that the use of rosuvastatin with cumulative using duration >12 months could correlate with 2.8-fold increased risk of lung cancer in women. We did not have specific comments on these results. Further prospective clinical studies of statins use are needed to elucidate this issue.
format Online
Article
Text
id pubmed-3532353
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-35323532012-12-29 Statins use and female lung cancer risk in Taiwan Lai, Shih-Wei Liao, Kuan-Fu Lin, Cheng-Li Sung, Fung-Chang Cheng, Ya-Hsin Libyan J Med Short Communication In this present study, we found that the use of rosuvastatin with cumulative using duration >12 months could correlate with 2.8-fold increased risk of lung cancer in women. We did not have specific comments on these results. Further prospective clinical studies of statins use are needed to elucidate this issue. Co-Action Publishing 2012-12-27 /pmc/articles/PMC3532353/ /pubmed/23272648 http://dx.doi.org/10.3402/ljm.v7i0.20123 Text en © 2012 Shih-Wei Lai et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Lai, Shih-Wei
Liao, Kuan-Fu
Lin, Cheng-Li
Sung, Fung-Chang
Cheng, Ya-Hsin
Statins use and female lung cancer risk in Taiwan
title Statins use and female lung cancer risk in Taiwan
title_full Statins use and female lung cancer risk in Taiwan
title_fullStr Statins use and female lung cancer risk in Taiwan
title_full_unstemmed Statins use and female lung cancer risk in Taiwan
title_short Statins use and female lung cancer risk in Taiwan
title_sort statins use and female lung cancer risk in taiwan
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532353/
https://www.ncbi.nlm.nih.gov/pubmed/23272648
http://dx.doi.org/10.3402/ljm.v7i0.20123
work_keys_str_mv AT laishihwei statinsuseandfemalelungcancerriskintaiwan
AT liaokuanfu statinsuseandfemalelungcancerriskintaiwan
AT linchengli statinsuseandfemalelungcancerriskintaiwan
AT sungfungchang statinsuseandfemalelungcancerriskintaiwan
AT chengyahsin statinsuseandfemalelungcancerriskintaiwan

Ejemplares similares